MIR3619

Across TCGA pan-cancer cohorts, MIR3619 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MIR3619 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR3619 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3619 expression acts as an unfavorable survival marker, although some lineages such as ESCA and ACC show a favorable association.

LUSC, ESCA, and LIHC are the cancer types where MIR3619 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.293	0.619	<.001	90	view →
ESCA	DFS	Quartile	All	0.658	0.375	<.001	65	view →
LIHC	OS	Tertile	II,III,IV	0.430	0.732	.001	42	view →
MESO	DFS	Tertile	II,III,IV	0.116	0.506	.006	36	view →
LAML	DFS	Median	All	0.251	0.510	.002	32	view →
STAD	DFS	Tertile	IV	0.112	0.465	.010	22	view →
OV	DFS	Tertile	IV	0.301	0.514	.016	20	view →
UVM	DFS	Tertile	All	0.213	0.761	.017	18	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	18	view →
UCEC	OS	Tertile	IV	0.507	0.772	.008	18	view →
TGCT	DFS	Tertile	All	0.175	0.807	<.001	18	view →
CHOL	OS	Tertile	All	0.285	0.681	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MIR3619–LUSC (OS)

Open the LUSC breakdown →